Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Hyperspectral Imaging (MHSI) Market Strategic Research Report

Global Medical Hyperspectral Imaging (MHSI) Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Hyperspectral Imaging (MHSI) Market
$26.572025
13%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Visible + Near Infrared Light, Short-Wavelength Infrared, Others

By Application: Diagnostic Centres, Hospitals, Research & Academic Centres, Pharmaceutical & Biotechnology Companies

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Headwall Photonics, Resonon, IMEC, EVK DI Kerschhaggl, Cubert, Galileo, Specim, Gooch & Housego, Surface Optics, Norsk Elektro Optikk A/S, Wayho Technology, BaySpec

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$26.57
Million USD
Forecast CAGR
13%
2025-2032
Forecast 2032
$62.5
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Medical Hyperspectral Imaging (MHSI) market size is predicted to grow from US$ 26.57 million in 2025 to US$ 61.91 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.

Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses. This help surgeon to identify which anatomical structures to preserve when removing sick tissues.

Americas has the largest global export quantity and manufacturers in Medical Hyperspectral Imaging (MHSI) market with about 44% market share in 2019, while the APAC is the second sales volume market for about 35% of the market and the number is still increasing.

In the industry, Headwall Photonics profits most in 2019 and recent years, while Resonon and IMEC ranked 2 and 3. The market share of them is 24.38%, 17.44% and 10.82% in 2019.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are three mainly types of Medical Hyperspectral Imaging (MHSI), including Visible + Near Infrared Light, Short-Wavelength Infrared and Other. And Visible + Near Infrared Light is the main type for Medical Hyperspectral Imaging (MHSI), and the Visible + Near Infrared Light reached a sales value of approximately 66.14% of global sales value.

Hyperspectral Imaging has a wide range of applications, the major applications including Diagnostic Centres, Hospitals, Research & Academic Centres

and Pharmaceutical & Biotechnology Companies, Pharmaceutical & Biotechnology Companies is the most important part, as the market share is nearly 42%.

This report presents a comprehensive overview of the global Medical Hyperspectral Imaging (MHSI) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Visible + Near Infrared Light
  • Short-Wavelength Infrared
  • Others

Segment by Application

  • Diagnostic Centres
  • Hospitals
  • Research & Academic Centres
  • Pharmaceutical & Biotechnology Companies

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Hyperspectral Imaging (MHSI) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Diagnostic Centres, Hospitals, Research & Academic Centres evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Hyperspectral Imaging (MHSI) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 13%
Regional growth momentum
Market share by segment
Key metrics
Base value
$26.57
2025
Forecast
$62.5
2032
CAGR
13%
2025–2032
Régions
5
global
Key companies
Headwall PhotonicsResononIMECEVK DI KerschhagglCubertGalileoSpecimGooch & Housego
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Visible + Near Infrared LightShort-Wavelength InfraredOthers
By Application
Diagnostic CentresHospitalsResearch & Academic CentresPharmaceutical & Biotechnology Companies

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Visible + Near Infrared Light
  • 3.1.3 Short-Wavelength Infrared
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Diagnostic Centres
  • 4.1.3 Hospitals
  • 4.1.4 Research & Academic Centres
  • 4.1.5 Pharmaceutical & Biotechnology Companies
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Headwall Photonics
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Resonon
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 IMEC
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 EVK DI Kerschhaggl
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cubert
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Galileo
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Specim
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Gooch & Housego
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Surface Optics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Norsk Elektro Optikk A/S
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Wayho Technology
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 BaySpec
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Medical Hyperspectral Imaging (MHSI) market?
The global Medical Hyperspectral Imaging (MHSI) market is estimated at US$ 26.57 million in 2025 (base year) and is projected to reach US$ 61.91 million by 2032.
How fast is the Medical Hyperspectral Imaging (MHSI) market expected to grow?
The market is expected to grow at a CAGR of 13.0% from 2026 to 2032, expanding from US$ 26.57 million in 2025 to US$ 61.91 million in 2032, roughly 2.3 times its base-year value.
What does the Medical Hyperspectral Imaging (MHSI) market cover?
Medical Hyperspectral Imaging (MHSI) can also support surgeons by offering them information that’s invisible to the naked eye – in real time. That medical hyperspectral image can be displayed on a screen. Or the hyperspectral information can be added as an overlay to the surgeon’s perspective by means of augmented reality glasses.
What are the main segments of the Medical Hyperspectral Imaging (MHSI) market by type?
By type, the market is segmented into Visible + Near Infrared Light, Short-Wavelength Infrared and Others.
Which applications drive demand in the Medical Hyperspectral Imaging (MHSI) market?
Key applications covered include Diagnostic Centres, Hospitals, Research & Academic Centres and Pharmaceutical & Biotechnology Companies.
Who are the key players in the Medical Hyperspectral Imaging (MHSI) market?
Key players profiled include Headwall Photonics, Resonon, IMEC, EVK DI Kerschhaggl, Cubert, Galileo, Specim and Gooch & Housego, among 12 companies covered in total.
Which regions and countries are covered for Medical Hyperspectral Imaging (MHSI)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Medical Hyperspectral Imaging (MHSI) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Diagnostic Centres, Hospitals and Research & Academic Centres, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Hyperspectral Imaging (MHSI) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.